Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα

• Main Authors: Julia Tittes (Author), Jennifer Brell (Author), Pia Fritz (Author), Constanze Jonak (Author), Georg Stary (Author), Julia M. Ressler (Author), Sarojinidevi Künig (Author), Wolfgang Weninger (Author), Johannes Stöckl (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Targeting of the proinflammatory cytokine interleukin 17A (IL-17A) or tumor necrosis factor alpha (TNFα) with the monoclonal antibodies (mAbs) ixekizumab or adalimumab, respectively, is a successful therapy for chronic plaque psoriasis. The effects of these treatments on immune...